SI
IDXX icon

Sofinnova Investments’s Idexx Laboratories IDXX Stock Holding History

Sofinnova Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-63,862
Closed -$31.1M – 74
2024
Q2 		$31.1M Sell
63,862
-11,362
-15% -$5.7M 1.62% 21
2024
Q1 		$40.6M Buy
+75,224
New +$41.1M 2.26% 14
2023
Q4 		– Sell
-77,881
Closed -$34.1M – 70
2023
Q3 		$34.1M Buy
77,881
+7,207
+10% +$3.59M 2.15% 17
2023
Q2 		$35.5M Buy
+70,674
New +$33.9M 2.32% 12

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments's IDXX Position: Q3 2024 in Review

Sofinnova Investments sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 63,862 shares — an estimated $31.1M sold.

Sofinnova Investments first reported a position in IDXX in Q2 2023 and held it in 4 quarters. The position peaked at $40.6M in Q1 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Sofinnova Investments reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Sofinnova Investments sold 63,862 Idexx Laboratories shares in Q3 2024, an estimated $31.1M.
  • Sofinnova Investments first reported a position in Idexx Laboratories in Q2 2023 and held it in 4 quarters.
  • Sofinnova Investments's Idexx Laboratories position peaked at $40.6M in Q1 2024.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Sofinnova Investments's 13F filing for Q3 2024, filed 13 Nov 2024.